# clm_7E2A196ABDE1

subject: Gilead Sciences (/record/gilead-sciences.md)  
predicate: quarterly_research_and_development  
value: 594,978,000 United States dollar  
valid_from: 2014-03-31  
valid_to: 2014-06-30  
published: 2014-05-07  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_B0CF038E671F  
last_updated: 2026-11-08  
cite: AsOf. "Gilead Sciences quarterly research and development: 594,978,000 United States dollar", as of 2014-03-31 (until 2014-06-30). Claim clm_7E2A196ABDE1, https://asof.is/claim/clm_7E2A196ABDE1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209514000024/0000882095-14-000024-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2014, filed 2014-05-07  

## Sources

- https://www.sec.gov/Archives/edgar/data/882095/000088209514000024/0000882095-14-000024-index.htm (primary, SEC EDGAR 10-Q Q1 FY2014, published 2014-05-07)

## Supersedes

- [Gilead Sciences](/record/gilead-sciences.md) | quarterly_research_and_development | 546,244,000 United States dollar | valid 2013-09-30 to 2014-03-31 | conf 0.95 | superseded | superseded_by [clm_7E2A196ABDE1](/claim/clm_7E2A196ABDE1.md) | [clm_C46B94F27B3E](/claim/clm_C46B94F27B3E.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.